Join the ERTC

The EURORDIS Round Table of Companies (ERTC) fosters an educational relationship and a constructive dialogue between EURORDIS and companies addressing rare diseases.

Since its inception 20 years ago, EURORDIS has gained expertise in dealing with the various public and private institutions involved in the rare disease and orphan drug fields. Through the ERTC programme, EURORDIS shares this expertise by bringing together industry, patient advocates, public officials and other experts to address patient needs. Discussions mainly take place at two ERTC workshops.

Pharmaceutical companies interested in rare diseases are confronted with very specific hurdles that lie in the path of product development for rare diseases in Europe. These are not the same as in the US where a specific rare disease policy has existed since 1983. The multicultural and heterogeneous legislative environment in the EU adds to the difficulty for orphan drug developers.

EURORDIS is fully aware of the bottlenecks and obstacles in developing products for rare diseases in Europe. In addition to being one of the main promoters of the EU Orphan Drug Regulation, we are a member of the COMP (Committee of Orphan Medicinal Products) and actively involved in the designation procedure of orphan medicinal products at the EMA (European Medicines Agency).

Membership benefits

  • Participation in 2 Round Table of Companies' Workshops per year focusing on issues suggested by the members. These workshops aim to accelerate the development as well as availability of treatments and health services in Europe. They also seek to build relationships with the patient community in a collaborative atmosphere that facilitates discussion (More information about ERTC workshops).
  • Opportunities to interact with other companies in a neutral venue
  • Opportunities for direct exchange of views with leaders of the rare disease community
  • Opportunities to develop partnerships and collaborations with patient groups 
  • Mention of ERTC members on EURORDIS ' website (see Members of the Round Table of Companies), with a logo and a direct link to the websites of the companies
  • Financial support acknowledged in the annual report
  • Timely reports, surveys and analysis relevant to the field of orphan drugs and rare diseases from different sources (EURORDIS, NORD, EMA, FDA, European Commission, EFPIA/EBE/EuropaBio, academic researchers).

 

Ruby member - 25 000 €

  • Up to 5 participants to workshops
  • Company listed on EURORDIS' website with logo and a link to the company's website
  • Financial support acknowledged in annual report

 

Emerald member - 10 000 €

  • Up to 2 participants to workshops
  • Company listed on EURORDIS' website with logo and a link to the company's website
  • Financial support acknowledged in annual report

 

Sapphire member - 5 000 €

  • 1 participant per workshop
  • Company listed on EURORDIS' website with logo and a link to company website
  • Financial support acknowledged in annual report

 

Round Table Membership

Membership application

For more information on applying for ERTC Membership, please contact:
Ms. Anne-Mary Bodin
Operations Unit Assistant
anne-mary.bodin@eurordis.org

We look forward to welcoming you to the EURORDIS Round Table of Companies.

The EURORDIS Round Table of Companies
EURORDIS
Plateforme Maladies Rares
96, rue Didot
75014 PARIS
FRANCE
Tel: + 33 (0)1 56 53 52 10


Page created: 19/08/2009
Page last updated: 11/09/2018
 
 
La voix des patients atteints de maladies rares en EuropeEURORDIS Donnant la voix, à l'international, aux personnes vivant avec une maladie rareRare Disease International Pour rapprocher patients, familles et experts sur un forum modéré multilingue, où partager leurs expériences. RareConnect Le programme Rare Barometer est une initiative d’EURORDIS qui vise à réaliser des sondages pour transformer les expériences des patients de maladie rare en faits et chiffres à communiquer aux décideurs politiques.Rare Barometer Campagne internationale de sensibilisation organisée chaque année le dernier jour de février, la Journée Internationale des Maladies Rares est une initiative d'EURORDISRare Disease Day Participez au plus grand événement réunissant tous les acteurs des maladies rares en Europe lors de Conférence européenne bisannuelle sur les maladies rares et les médicaments orphelins (European Conference on Rare Diseases and Orphan Products, ou ECRD). L'ECRD est une initiative d'EURORDISEuropean Conference on Rare Diseases